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Nonheme Fe(II)/αKG-dependent oxygenases make up a large superfamily of enzymes catalyzing diverse reactions, including demethylations, hydroxylations, ring expansions, and epoxidations.^[@ref1],[@ref2]^ Many of these enzymes have important functions in human health because of their role in O~2~ sensing,^[@ref3],[@ref4]^ DNA repair,^[@ref5],[@ref6]^ histone demethylation,^[@ref7]^ and RNA processing,^[@ref8],[@ref9]^ making this superfamily a growing class of therapeutic targets.^[@ref10],[@ref11]^ As the consensus chemical mechanism is an ordered sequential one, with O~2~ reacting at the Fe prior to oxidation of the primary substrate (Scheme [1](#sch1){ref-type="scheme"}),^[@ref12],[@ref13]^ identifying features of the active site by which substrate binding stimulates O~2~ reactivity is crucial to understanding the chemistry of this superfamily. An ideal enzyme for interrogating these connections is Factor Inhibiting HIF (FIH), because of the extensive contacts with the primary substrate.^[@ref14]^

![Proposed Chemical Mechanism of FIH](bi-2014-00703s_0005){#sch1}

Human cells sense O~2~ through the hypoxia inducible factor (HIF) pathway, which is controlled by a small number of αKG oxygenases, including FIH.^[@ref15],[@ref16]^ HIF is an αβ dimeric transcription factor that regulates numerous genes involved in tissue development, controlling processes such as glycolysis, erythropoiesis, and angiogenesis.^[@ref1],[@ref17]−[@ref19]^ In the presence of O~2~, FIH hydroxylates the β-carbon of HIF1α-Asn^803^,^[@ref20]^ which is found in the C-terminal activation domain (CTAD) of HIF1α. CTAD-Asn^803^ hydroxylation blocks recruitment of the cAMP response element-binding protein (CREBP), preventing HIF-dependent gene transcription.^[@ref4],[@ref21]^ The connection between CTAD-Asn^803^ positioning and O~2~ reactivity is critical to understanding how substrate stimulates O~2~ activation in this enzyme superfamily, as well as illuminating FIH's role as an O~2~ sensor.

The consensus chemical mechanism for FIH is based upon an array of kinetic and spectroscopic studies of FIH and other αKG oxygenases. Kinetic studies of thymine hydroxylase, FIH, CAS, and TauD support the ordered, sequential binding of αKG and primary substrate followed by O~2~.^[@ref22]−[@ref25]^ Although αKG, O~2~, and an oxidizable compound are all substrates for these enzymes, we will refer to the oxidizable substrate as the "primary substrate". Spectroscopic studies of CAS,^[@ref26]−[@ref28]^ TfdA,^[@ref29]^ FIH,^[@ref30]^ and TauD^[@ref31]^ revealed that the Fe(II) released an aquo ligand after the primary substrate bound, creating a site for O~2~ binding. Binding and activation of O~2~ lead to the oxidative decarboxylation of αKG and the formation of a highly reactive ferryl intermediate (Scheme [1](#sch1){ref-type="scheme"}). Although the precise sequence of intermediates is not known, the ferryl intermediate has been observed in TauD^[@ref32]−[@ref34]^ and P4H,^[@ref35]^ demonstrating that H atom abstraction by the ferryl intermediate occurs,^[@ref36]^ with the next step likely to be ^•^OH rebound to hydroxylate the primary substrate.

The most intriguing feature of the consensus mechanism is that binding the primary substrate stimulates O~2~ reactivity.^[@ref22],[@ref37],[@ref38]^ Loss of an aquo ligand when the primary substrate is bound opens a coordination site for O~2~ binding, as observed upon binding of the primary substrate in several αKG-dependent oxygenases, including CytC3, TauD, CAS, and FIH.^[@ref26],[@ref30],[@ref31]^ Although aquo release is central to the widely accepted model for substrate-stimulated O~2~ activation,^[@ref39]^ we note that simple ligand exchange is insufficient for O~2~ activation in these enzymes. For example, substrate binding to FIH leads to only fractional release of the aquo ligand,^[@ref30]^ and mutagenesis suggests that hydrogen bond donors to the αKG are necessary for full activity in this enzyme.^[@ref40]^ Computational studies^[@ref41]−[@ref44]^ and mechanistic probes^[@ref45]−[@ref47]^ further point to turnover being limited by steps after O~2~ binds to the Fe(II). These and related observations lead us to propose that substrate-stimulated O~2~ reactivity arises from bonding changes throughout the active site, ranging from aquo release at the iron cofactor to altered contacts in the second coordination sphere.

A focus of this research in our lab is to identify those active site features that change upon substrate binding to stimulate O~2~ activation in αKG oxygenases. Although the precise sequence of intermediates formed during turnover is not known, we define O~2~ activation as the steps between O~2~ binding and oxidative decarboxylation (Scheme [1](#sch1){ref-type="scheme"}) by virtue of the irreversible chemistry; this step is depicted as the nucleophilic attack of the putative ferric superoxide on the α-keto position of αKG. On the basis of known crystal structures of FIH,^[@ref14],[@ref48],[@ref49]^ we have used point mutagenesis to identify several essential second-coordination sphere interactions in FIH, including those hydrogen bonding to Fe(II) ligands, as well as FIH-Gln^239^, an anchor residue that forms two hydrogen bonds with the target residue, CTAD-Asn^803^ (Figure [1](#fig1){ref-type="fig"}).^[@ref14]^ Intriguingly, disruption of this two-point hydrogen bond in the FIH-Gln^239^ → Asn point mutant led to a decrease in *k*~cat~ of 250-fold, but a negligible change in *K*~M(CTAD)~.^[@ref40]^ This was attributed to a combination of steric hindrance near the open coordination site on Fe(II) and incorrect CTAD positioning for the HAT step. Subsequently, it was shown that an irreversible step associated with O~2~ activation was rate-limiting in wild-type FIH (WT-FIH),^[@ref25]^ suggesting that the slower turnover for the Gln^239^ → Asn variant could arise from slower O~2~ activation. This suggests the intriguing possibility that target residue position may stimulate O~2~ activation and that the overall structure of the active site is crucial for O~2~ activation.

![CTAD-Asn^803^ (CTAD, blue) positioned by FIH-Gln^239^ (FIH, gray) over the active site. Hydrogen bonding distances are given in angstroms (Protein Data Bank entry 1H2L([@ref14])).](bi-2014-00703s_0002){#fig1}

This study tests the role of Gln^239^ in substrate hydroxylation in αKG oxygenases. As FIH hydroxylates a specific target residue within a large peptide (CTAD-Asn^803^), our focus was directed at this target residue pocket, formed by the side chains of FIH residues Tyr^102^, His^199^, Arg^238^, and Gln^239^ (Figure [1](#fig1){ref-type="fig"}). Five FIH-Gln^239^ → X variants were prepared (X = Ala, Asn, Glu, His, and Leu) to vary the bulk and hydrogen bonding potential within the target residue pocket. Although these variants exhibited significantly reduced steady-state rate constants that decreased monotonically with increasing residue bulk, CTAD binding affinity was unaffected by mutation. In contrast to the case in WT-FIH, O~2~ activation was appreciably uncoupled from CTAD hydroxylation in the variants; uncoupled O~2~ activation was partially suppressed in D~2~O. These data establish that the proper orientation of CTAD-Asn^803^ by FIH-Gln^239^ is required for substrate hydroxylation, most likely because of the need for the proper target residue positioning during steps after O~2~ activation.

Experimental Procedures {#sec2}
=======================

Materials {#sec2.1}
---------

All reagents were purchased from commercial vendors and were not further purified, with the exception of the 39-mer CTAD peptide. The 39-mer CTAD peptide corresponding to the C-terminal activation domain of human HIF1α, (HIF1α^788--826^) contained a Cys^800^ → Ala change (underlined) (DESGLPQLTSYD[A]{.ul}EV**N**APIQGSRNLLQGEELLRALDQVN). This was purchased as a desalted peptide from EZBiolab (Carmel, IN) with free N- and C-termini. The peptide was purified as previously described using reverse-phase high-performance liquid chromatography (RP-HPLC) to obtain \>95% pure CTAD.^[@ref25]^ The 19-mer CTAD peptide corresponding to HIF1α^788--806^ also contained a Cys^800^ → Ala change and was purchased at \>95% purity from EZBiolab with free N- and C-termini. The CTAD-Asn^803^ → Gln peptide was the 19-mer sequence but contained the Asn^803^ → Gln change (DESGLPQLTSYDAEV**Q**API).

FIH Mutations {#sec2.2}
-------------

The Stratagene QuikChange mutagenesis kit was used to introduce the mutations into the pET28a-FIH construct.^[@ref50]^ All mutations were sequenced (Genewiz) to confirm that the DNA sequence contained only the desired point mutation. Sequenced plasmids were transformed into BL21(DE3) cells for protein expression.

Protein Expression and Purification {#sec2.3}
-----------------------------------

WT-FIH and all variants were overexpressed in *Escherichia coli* with an N-terminal His~6~ tag and purified as previously described.^[@ref25]^ Three additional residues (NH~2~-GlySerHis-) from the fusion protein remained on the N-terminus following thrombin cleavage. Purified FIH was buffer-exchanged into 50 mM HEPES (pH 7.00). The purity (\>95%) of each variant was assessed by sodium dodecyl sulfate--polyacrylamide gel electrophoresis.

Steady-State Kinetics Assays {#sec2.4}
----------------------------

All assays used saturating concentrations of FeSO~4~ (25 μM) and ascorbate (2 mM) and an ambient O~2~ concentration (217 μM at 37.0 °C) and were performed in 50 mM HEPES (pH 7.00) at 37.0 °C unless specifically noted otherwise. DTT (200 μM) was added to assays for FIH-Gln^239^ → His and FIH-Gln^239^ → Glu when these variants were tested in D~2~O, as nonlinear progress curves were observed otherwise. Assays in which CTAD was the varied substrate (from 15 to 300 μM) utilized a saturating αKG concentration (500 μM). Assays with αKG as the varied substrate (from 2.5 to 100 μM) utilized a fixed CTAD concentration of 100 μM \[∼*K*~M(CTAD)~\] to conserve on the use of the peptide. Assay reagents were mixed and incubated for 2 min at 37.0 °C before the addition of enzyme (\[E\]~T~ = 1.5--10 μM). Reaction aliquots (5 μL) were quenched with a 75% acetonitrile/0.2% TFA mixture (20 μL) saturated with 3,5-dimethoxy-4-hydroxycinnamic acid and analyzed for peptide hydroxylation using a Bruker Daltonics Omniflex matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS) instrument. Initial rates were determined from five to seven quenched time points (0 to ∼15% fractional conversion). The nonlinear least-squares fitting of initial rate data to the Michaelis--Menten equation yielded the apparent steady-state rate constants, *k*~cat~ and *k*~cat~/*K*~M~. All assays were replicated a minimum of three times.

Solvent Kinetic Isotope Effects (SKIEs) {#sec2.5}
---------------------------------------

Steady-state assays for SKIEs were performed under the same conditions reported above, with the exception that all reagents were prepared in D~2~O. Deuterium oxide (D, 99.9%) was purchased from Cambridge Isotope Laboratories (Andover, MA) and used as received. Working FIH stock solutions were made by diluting high-concentration stocks from H~2~O into D~2~O containing 50 mM HEPES (pD 7.00). Assays were performed in 50 mM HEPES (pD 7.00), with a final D~2~O percentage estimated to be 96%. SKIEs were calculated from the direct comparison of kinetic parameters observed in buffers containing H~2~O and D~2~O; e.g., ^D~2~O^*k*~cat~ = *k*~cat(H~2~O)~/*k*~cat(D~2~O)~.

Succinate Quantification {#sec2.6}
------------------------

The coupling between the two half-reactions was determined by monitoring the production of succinate and CTAD^OH^ concentrations in several quench points from a common reaction. Reactions of αKG (500 μM), FeSO~4~ (25 μM), CTAD (350 μM), and FIH (5--10 μM) were conducted at 37.0 °C and analyzed similarly using previously reported procedures.^[@ref25],[@ref40],[@ref47]^ As HEPES interfered with the succinate analysis, the reaction buffer consisted of 50 mM Tris (pL 7.00). A Hamilton PRP-X300 anion exclusion column was used to separate the succinate produced from the quenched reactions, and UV detection at 210 nm was used to determine the succinate concentration. Using aliquots from the same quenched assay, a Bruker Daltonics Omniflex MALDI-TOF MS was used to determine the CTAD^OH^ concentration. The coupling ratio (*C*) was determined by taking the ratio of the rate of succinate formation and the rate of CTAD^OH^ formation from matched time points.

Fluorescence Spectroscopy {#sec2.7}
-------------------------

The FIH--CTAD binding constants were measured through quenching of the intrinsic tryptophan fluorescence of (Co + αKG)FIH upon CTAD binding at room temperature (∼20 °C). The fluorescence cuvette contained FIH (1.5 μM), CoSO~4~ (25 μM), αKG (500 μM), and 50 mM HEPES (pH 7.05). This solution was titrated with 50 mM HEPES (pH 7.05) containing CTAD (1 mM), FIH (1.5 μM), CoSO~4~ (25 μM), and αKG (500 μM). All titrations were performed aerobically. After each addition of titrant, samples were gently mixed and allowed to equilibrate for 5 min before being excited at 295 nm. The fluorescence intensities at 330 nm were plotted versus the total CTAD concentration and fit using eq [1](#eq1){ref-type="disp-formula"}where *I* is the measured fluorescence intensity, \[E\] is the protein concentration, \[S\] is the total CTAD concentration, *n* is the number of binding sites, and *K*~D~ is the binding affinity. The initial intensity (*I*~0~) and final intensity (*I*~f~) were obtained from measured spectra.

Results {#sec3}
=======

Variants of FIH-Gln^239^ were used to test the effect of target residue positioning on substrate hydroxylation in FIH. The variants were designed to vary hydrogen bonding potential (Gln^239^ → Glu and Gln^239^ → His) and cavity size (Gln^239^ → Ala, Gln^239^ → Asn, and Gln^239^ → Leu) in the target residue pocket of FIH. The Gln^239^ variants were kinetically characterized in the steady state with CTAD as the varied substrate, giving the apparent rate constants *k*~cat~ and *k*~cat~/*K*~M(CTAD)~. The kinetic characterization revealed significantly diminished rate constants for turnover, leading us to determine the binding affinity of CTAD as well as the coupling ratio of the two half-reactions for each point mutant.

Kinetic Characterization of Gln^239^ → X Variants {#sec3.1}
-------------------------------------------------

We hypothesized the positioning of CTAD-Asn^803^ by FIH-Gln^239^ was necessary to support turnover and therefore focused our studies on steady-state characterization by monitoring CTAD^OH^ formation via MALDI-TOF. Although O~2~ uptake was the first method that we considered, the slow turnover for FIH makes high-precision kinetic determinations by this method challenging. Assays using fixed concentrations of αKG (500 μM) and O~2~ (217 μM) and varied concentrations of CTAD (15--300 μM) were used to measure initial rates, which where then fit to the Michaelis--Menten equation to obtain the apparent steady-state rate constants, *k*~cat~ and *k*~cat~/*K*~M(CTAD)~. The Michaelis constant for αKG was determined for each variant \[*K*~M(αKG)~ = 4--7 μM\], which was slightly lower than that for WT-FIH \[*K*~M(αKG)~ = 16 μM\]. Because of the O~2~ concentration is subsaturating, the apparent *k*~cat~ encompasses all steps after CTAD binding, including those involved in O~2~ binding and activation. All of the Gln^239^ → X variants exhibited a significant decrease in *k*~cat~ (Figure [2](#fig2){ref-type="fig"}). The Gln^239^ → Ala (*k*~cat~ = 1.27 ± 0.10 min^--1^) variant was most active, as the *k*~cat~ decreased 20-fold relative to that of WT-FIH, whereas the *k*~cat~ for Gln^239^ → Asn (0.14 ± 0.02 min^--1^) decreased 200-fold. The *k*~cat~ for variants capable of one-point hydrogen bonding decreased \>1200-fold: Gln^239^ → His (0.023 ± 0.003 min^--1^) and Gln^239^ → Glu (0.024 ± 0.002 min^--1^). We were unable to observe hydroxylation from the Gln^239^ → Leu variant.

![Steady-state kinetics of Q239A in H~2~O. FIH (1.5 μM), ascorbate (2 mM), αKG (500 μM), FeSO~4~ (25 μM), and CTAD (0--300 μM) were in 50 mM HEPES (pH 7.00). The inset shows the steady-state kinetics of Q239N (▲),Q239H (■), and Q239E (◆) in H~2~O. FIH (1.5--30 μM), ascorbate (2 mM), αKG (500 μM), FeSO~4~ (25 μM), and CTAD (0--300 μM) were in 50 mM HEPES (pH 7.00).](bi-2014-00703s_0003){#fig2}

Steps from CTAD binding through the first irreversible step (decarboxylation) comprise *k*~cat~/*K*~M(CTAD)~ (Scheme [2](#sch2){ref-type="scheme"}). The effect of each point variant on *k*~cat~/*K*~M(CTAD)~ was nearly identical to their effect on *k*~cat~, indicating that the variants affected a step that was separate from CTAD binding.

![Minimal Chemical Scheme for Uncoupling](bi-2014-00703s_0006){#sch2}

We tested the activity of FIH-Gln^239^ → Asn using a 19-mer CTAD peptide containing the complementary CTAD-Asn^803^ → Gln point mutation, which switched the residues at this interface. This switch mutation was designed to restore the bulk and hydrogen bonds observed between WT-FIH and WT-CTAD. However, the activity level was below our detection limit (0.002 min^--1^), as hydroxylated CTAD-Asn^803^ → Gln was not detected upon being incubated with FIH-Gln^239^ → Asn. WT-FIH was similarly unreactive toward this variant CTAD, as WT-FIH hydroxylated the 19-mer WT-CTAD with an appreciable rate, but did not hydroxylate the variant CTAD (Table [1](#tbl2){ref-type="other"}).

###### Initial Rates for 19-mer Peptides CTAD and CTAD-N803Q[a](#t2fn1){ref-type="table-fn"}

          initial rate (min^--1^)   
  ------- ------------------------- -----------------------------------------
  WT      0.70                      \<0.005[b](#t2fn2){ref-type="table-fn"}
  Q239N   \<0.005                   \<0.005[b](#t2fn2){ref-type="table-fn"}

Assays contained ascorbate (2 mM), αKG (500 μM), FeSO~4~ (25 μM), and 19-mer CTAD (400 μM) in 50 mM HEPES (pH 7.00) at 37.0 °C. The CTAD peptide used contained 19 residues.

No activity detected; estimated detection limit, if active.

Binding Affinity of CTAD for Gln^239^ → X Variants {#sec3.2}
--------------------------------------------------

The binding affinity of each FIH variant for CTAD was measured by titration using the intrinsic tryptophan fluorescence of FIH. A solution containing CTAD (1 mM) was titrated into a solution containing FIH (1.5 μM) while the fluorescence at 330 nm was monitored (λ~ex~ = 295 nm); both solutions were anaerobic and contained CoSO~4~ (25 μM) and αKG (500 μM). The change in fluorescence intensity (330 nm) was plotted as a function of CTAD concentration and fit to eq [1](#eq1){ref-type="disp-formula"}. The experimentally determined *K*~D~ for each point mutant (Table [2](#tbl1){ref-type="other"}) was similar to that of WT-FIH (78 ± 7 μM), indicating the thermodynamics of CTAD binding was not affected by point mutation.

###### Apparent Kinetic Parameters for FIH and Its Variants[a](#t1fn1){ref-type="table-fn"}

          *k*~cat~ (min^--1^)[b](#t1fn2){ref-type="table-fn"}   *k*~cat~/*K*~M(CTAD)~ (μM^--1^ min^--1^)[b](#t1fn2){ref-type="table-fn"}   *K*~M(CTAD)~ (μM)[b](#t1fn2){ref-type="table-fn"}   *K*~D(CTAD)~ (μM)[c](#t1fn3){ref-type="table-fn"}   *K*~M(αKG)~ (μM)[d](#t1fn4){ref-type="table-fn"}
  ------- ----------------------------------------------------- -------------------------------------------------------------------------- --------------------------------------------------- --------------------------------------------------- --------------------------------------------------
  WT      30 ± 2.5[e](#t1fn5){ref-type="table-fn"}              0.4 ± 0.1[e](#t1fn5){ref-type="table-fn"}                                  70 ± 20[e](#t1fn5){ref-type="table-fn"}             78 ± 7[f](#t1fn6){ref-type="table-fn"}              16 ± 3.0
  Q239A   1.3 ± 0.10                                            0.021 ± 0.002                                                              61 ± 10                                             100 ± 16                                            5.0 ± 0.5
  Q239N   0.14 ± 0.02                                           2.0 × 10^--3^ ± 8 × 10^--4^                                                74 ± 30                                             98 ± 10                                             4.0 ± 0.4
  Q239H   0.023 ± 0.003                                         (3.4 ± 1) × 10^--4^                                                        68 ± 18                                             64 ± 14                                             7.0 ± 1.4
  Q239E   0.024 ± 0.002                                         3.4 × 10^--4^ ± 7 × 10^--5^                                                71 ± 10                                             75 ± 15                                             4.7 ± 2.0
  Q239L   \<0.005[g](#t1fn7){ref-type="table-fn"}               \<8 × 10^--5^[g](#t1fn7){ref-type="table-fn"}                              ND[h](#t1fn8){ref-type="table-fn"}                  80 ± 8                                              ND[h](#t1fn8){ref-type="table-fn"}

In 50 mM HEPES (pH 7.00) at 37.0 °C.

Assays in which CTAD was the varied substrate, in ascorbate (2 mM), αKG (500 μM), FeSO~4~ (25 μM), and CTAD (0--300 μM).

Determined using intrinsic tryptophan fluorescence with Co-substituted enzyme.

Assays in which αKG was the varied substrate, in ascorbate (2 mM), αKG (2--200 μM), FeSO~4~ (25 μM), and CTAD (100 μM).

From ref ([@ref25]).

From ref ([@ref30]).

No activity detected; estimated detection limits as reported.

Not determined.

Uncoupled Turnover in the Gln^239^ → X Variants {#sec3.3}
-----------------------------------------------

The kinetic parameters of the Gln^239^ → X mutations led us to explore the coupling of O~2~ activation to substrate hydroxylation. We hypothesized that if the conformational state of CTAD-Asn^803^ were incorrect for HAT, then the two half-reactions would uncouple to produce more succinate than hydroxylated product (CTAD^OH^). Quenched aliquots from reaction mixtures containing saturating concentrations of αKG (500 μM) and CTAD (350 μM) in 50 mM Tris (pH 7.00) were analyzed for CTAD^OH^ via MALDI-TOF MS and succinate via HPLC. Tris buffer was used for these assays to minimize the background signal in the HPLC chromatograms that arose due to buffer components.

The coupling values for the Gln^239^ → X (X = Ala, Asn, Glu, and His) variants were obtained by taking the ratio of the rates of formation for succinate and CTAD^OH^. Variants produced three to five succinates per equivalent of CTAD^OH^; succinate formation was observed for the Gln^239^ → Leu variant \[*k*~obs(suc)~ = 0.08 min^--1^\], indicating O~2~ activation occurred even though CTAD hydroxylation was not detected for this variant (Table [3](#tbl3){ref-type="other"}). This uncoupling is similar to the values found previously for second-coordination sphere variants of FIH.^[@ref40]^

###### Coupling of Succinate and CTAD^OH^ Concentrations for FIH and Variants[a](#t3fn1){ref-type="table-fn"}

          *k*~obs(H~2~O)~ (\[succinate\] min^--1^ \[FIH\]^−1^)   *C*~H~2~O~[b](#t3fn2){ref-type="table-fn"}   *C*~D~2~O~[b](#t3fn2){ref-type="table-fn"}
  ------- ------------------------------------------------------ -------------------------------------------- --------------------------------------------
  WT      28 ± 2                                                 1.0 ± 0.1                                    1.0 ± 0.1
  Q239A   5.5 ± 0.3                                              4 ± 1                                        1.4 ± 0.2
  Q239N   0.49 ± 0.08                                            3.3 ± 0.3                                    2.2 ± 0.2
  Q239H   0.06 ± 0.02                                            3 ± 1                                        ND[c](#t3fn3){ref-type="table-fn"}
  Q239E   0.07 ± 0.03                                            5 ± 1                                        ND[c](#t3fn3){ref-type="table-fn"}
  Q239L   0.08 ± 0.02                                            ND[c](#t3fn3){ref-type="table-fn"}           ND[c](#t3fn3){ref-type="table-fn"}

Reaction mixtures contained FIH (5--10 μM), αKG (500 μM), FeSO~4~ (25 μM), and CTAD (350 μM) in 50 mM Tris (pL 7.00) at 37 °C.

*C* = (moles of succinate per minute)/(moles of CTAD^OH^ per minute).

Not determined.

The coupling of WT, Gln^239^ → Ala, and Gln^239^ → Asn in deuterated buffer was used to determine if the coupling ratio changed between protonated and deuterated buffers. The coupling for WT FIH in H~2~O (*C* = 1.0 ± 0.1) and D~2~O (*C* = 1.0 ± 0.1) was in agreement with our previous work,^[@ref25]^ showing WT remains tightly coupled under all tested conditions. However, the coupling ratio in D~2~O for Gln^239^ → Ala (*C* = 1.4 ± 0.2) and Gln^239^ → Asn (*C* = 2.2 ± 0.2) approached unity, indicating that solvent deuteration led to more tightly coupled turnover for these variants.

Solvent Kinetic Isotope Effects (SKIEs) {#sec3.4}
---------------------------------------

SKIEs on both *k*~cat~ and *k*~cat~/*K*~M(CTAD)~ were used to test the importance of solvent-dependent steps during turnover. Initial rates from steady-state assays using saturating αKG concentrations (500 μM), ambient O~2~ concentrations (217 μM), and varied concentrations of CTAD (15--300 μM) were fit to the Michaelis--Menten equation (Figure [3](#fig3){ref-type="fig"}). Turnover was faster in D~2~O with both WT-FIH and each variant, leading to an inverse SKIE on *k*~cat~ and *k*~cat~/*K*~M(CTAD)~ (Table [4](#tbl4){ref-type="other"}). However, these SKIEs must be considered in the context of the solvent-dependent uncoupling observed for the variants.^[@ref51]^

![Steady-state kinetics of Q239A in H~2~O (●) and 96% D~2~O (■) buffers. FIH (1.5--30 μM), ascorbate (2 mM), αKG (500 μM), FeSO~4~ (25 μM), and CTAD (0--300 μM) were in 50 mM HEPES (pL 7.00).](bi-2014-00703s_0004){#fig3}

###### Apparent Kinetic Parameters in D~2~O and SKIEs for FIH and Its Variants[a](#t4fn1){ref-type="table-fn"}

                                       *k*~cat~ (min^--1^)[b](#t4fn2){ref-type="table-fn"}   *k*~cat~/*K*~M(CTAD)~ (μM^--1^ min^--1^)[b](#t4fn2){ref-type="table-fn"}   ^D~2~O^*k*~cat~[c](#t4fn3){ref-type="table-fn"}   ^D~2~O^*k*~cat~/*K*~M(CTAD)~[d](#t4fn4){ref-type="table-fn"}
  ------------------------------------ ----------------------------------------------------- -------------------------------------------------------------------------- ------------------------------------------------- --------------------------------------------------------------
  WT[e](#t4fn5){ref-type="table-fn"}   59 ± 2                                                1.09 ± 0.11                                                                0.51 ± 0.07                                       0.40 ± 0.07
  Q239A                                2.55 ± 0.21                                           0.044 ± 0.011                                                              0.50 ± 0.05                                       0.48 ± 0.15
  Q239N                                0.27 ± 0.02                                           0.005 ± 0.001                                                              0.50 ± 0.06                                       0.41 ± 0.18
  Q239H                                0.050 ± 0.003                                         2.0 × 10^--3^ ± 8 × 10^--4^                                                0.46 ± 0.07                                       0.17 ± 0.06
  Q239E                                0.046 ± 0.002                                         (8 ± 3) × 10^--4^                                                          0.52 ± 0.05                                       0.41 ± 0.16
  Q239L                                ND[f](#t4fn6){ref-type="table-fn"}                    ND[f](#t4fn6){ref-type="table-fn"}                                         ND[f](#t4fn6){ref-type="table-fn"}                ND[f](#t4fn6){ref-type="table-fn"}

In 50 mM HEPES (pD 7.00) at 37.0 °C.

Determined from assays with CTAD as the varied substrate, in ascorbate (2 mM), αKG (500 μM), FeSO~4~ (25 μM), and CTAD (0--250 μM); χ~D~2~O~ = 0.96.

^D~2~O^*k*~cat~ = *k*~cat(H~2~O)~/*k*~cat(D~2~O)~.

^D~2~O^*k*~cat~/*K*~M(CTAD)~ = \[*k*~cat~/*K*~M(CTAD)~ in H~2~O\]/\[*k*~cat~/*K*~M(CTAD)~ in D~2~O\].

From ref ([@ref25]).

Not determined.

Discussion {#sec4}
==========

The ordered sequential consensus mechanism for αKG oxygenases leads to coupled turnover when primary substrate binding stimulates reactivity toward O~2~, a phenomenon termed substrate-induced activity enhancement,^[@ref52]^ priming,^[@ref53]^ or triggering^[@ref54]^ by different groups. As primary substrate does not directly bind to the Fe(II), altered local contacts within the active site likely stimulate O~2~ activation. Although the idea of stimulated O~2~ activation refers to the empirical observation of increased turnover rates induced by substrate binding, the dominant model used to explain this focuses on aquo release, which creates an open coordination site for O~2~ binding.^[@ref39]^ In our opinion, broader changes within the active site are correlated with this effect, such as the position of the primary substrate.

FIH is notable in that enzyme--substrate contacts are quite extensive because the substrate is a large peptide (CTAD), with the target residue positioned above the Fe by a two-point hydrogen bond to the side chain of an anchoring residue, FIH-Gln^239^.^[@ref14],[@ref55]^ This study varied the sterics and H-bonding potential of this anchor residue to test its role in hydroxylating CTAD-Asn^803^.

CTAD Hydroxylation Is Slowed by Gln^239^ Variants {#sec4.1}
-------------------------------------------------

Each of the Gln^239^ → X variants (X = Ala, Asn, Glu, His, or Leu) altered the hydrogen bond potential and/or bulk of the target residue pocket, disrupting the positioning of the target residue. This incorrect positioning could have impacted any one of several steps within the kinetic mechanism, which may be distinguished through analysis of steady-state kinetic parameters and coupling ratios. The significant reduction in *k*~cat~ and *k*~cat~/*K*~M(CTAD)~ relative to those of WT-FIH indicated that the anchor residue played a prominent role in supporting turnover. Keeping in mind the observation that the binding affinity of CTAD was unchanged from that of WT-FIH (Table [2](#tbl1){ref-type="other"}), we are led to conclude that the predominant role of FIH-Gln^239^ is to position substrate for a chemical step rather than to bind CTAD.

Although it may seem surprising that the anchor residue FIH-Gln^239^ contributes very little to the CTAD binding affinity, this is consistent with prior studies of CTAD variants. As the length of the CTAD has been shown to have a significant affect on the *K*~M~,^[@ref56]^ and the binding affinity of WT-FIH for CTAD is indistinguishable from the Michaelis constant, it appears that the dominant factor in CTAD binding is the surface contact with FIH, with only minor contributions from the target residue pocket. Alanine scanning point mutagenesis of CTAD revealed that CTAD-Val^802^ was the most significant residue for CTAD binding, with a 2-fold increase in the *K*~M(CTAD)~ for the CTAD-Val^802^ → Ala variant.^[@ref57]^ Molecular dynamics studies suggested that this mutation led to reorientation of Asn^803^, perhaps because of disruption of the tight turn conformation in residues 801--803 of CTAD. Further support for a minimal impact of FIH-Gln^239^ on CTAD binding is the observation that FIH hydroxylates substrates with target residues other than asparagine.^[@ref58],[@ref59]^ The structural features of these substrates suggest the overall contact between FIH and the CTAD peptide is important in determining substrate binding to FIH.^[@ref59],[@ref60]^

Inverse SKIEs and Coupling {#sec4.2}
--------------------------

We recently reported inverse SKIEs for WT FIH, on both *k*~cat~ and *k*~cat~/*K*~M(CTAD)~.^[@ref25]^ This was due to the isotopically sensitive metal--aquo fractionation prior to a rate-limiting step for WT-FIH. Importantly, WT-FIH exhibited fully coupled turnover, such that O~2~ activation always led to substrate hydroxylation. Consequently, it was deduced that the rate-limiting step for *k*~cat~ and *k*~cat~/*K*~M(CTAD)~ was an irreversible step immediately after aquo release. This step is depicted as the oxidative decarboxylation of αKG in Scheme [1](#sch1){ref-type="scheme"}.

For each of the Gln^239^ → X variants, inverse SKIEs were measured on both *k*~cat~ and *k*~cat~/*K*~M(CTAD)~ when determined from the rate of CTAD^OH^ formation (Table [4](#tbl4){ref-type="other"}). Although the SKIE data resembled those reported for WT-FIH, turnover for these variants was significantly uncoupled, which precluded the use of SKIEs to diagnose rate-limiting steps in the steady state. Nevertheless, uncoupling in the variants depended on solvent isotopic composition (Table [3](#tbl3){ref-type="other"}), suggesting that the ferryl intermediate could form even when CTAD was improperly positioned. The fact that *C* approached unity in D~2~O for these variants suggested that the main effect of the Gln^239^ → X change was to perturb the hydroxylation step.

Sterics and H-Bonding Impact Substrate Hydroxylation {#sec4.3}
----------------------------------------------------

A simple model to explain how the target residue pocket impacts productive turnover is one in which multiple conformational states of the target residue are adopted but only one conformation supports hydroxylation. X-ray crystal structures of (M+αKG)FIH bound to CTAD^[@ref14]^ or Notch-derived peptides^[@ref55]^ revealed that the target residue adopted a specific rotameric conformation, with a side chain torsional angle (HN--C~α~--C~β~--C~γ~) of −71°. This is observed for both Notch target residues Notch-Asn^210^ and Notch-Asn^1945^ \[Protein Data Bank (PDB) entries 3P3P and 3P3N, respectively\]. As a good deal of flexibility near Gln^239^ was observed crystallographically for (Fe+αKG)FIH when CTAD was absent (PDB entry 1MZF),^[@ref48]^ changing the hydrogen bonding potential and packing density of this anchor residue should alter the target residue position above the Fe(II). The significant reduction in catalytic efficiency for each point mutant strongly suggests that the major role of FIH-Gln^239^ is to stabilize the proper rotamer of CTAD-Asn^803^ that can undergo hydroxylation during turnover.

The kinetic data further suggest that packing near the target residue may also impact O~2~ activation in FIH. The overall trend in the kinetic parameters measured by coupled turnover (Table [2](#tbl1){ref-type="other"}) was dominated by bulk, as the kinetic parameters for the Gln^239^ → X point variants decreased monotonically in a series: X = (Ala \> Asn \> Glu and His ≫ Leu). As the kinetic parameters of the variants listed in Table [2](#tbl1){ref-type="other"} are functions of all steps leading to CTAD hydroxylation, it is not possible to separately identify the impact of the variants on O~2~ activation. However, the coupling data directly measured succinate production (Table [4](#tbl4){ref-type="other"}), which reports directly on O~2~ activation. The rates of succinate production clearly showed that each variant produced succinate much more slowly that WT-FIH, suggesting that O~2~ activation was slowed in these variants. As the packing about CTAD-Asn^803^ is quite tight in WT-FIH,^[@ref14]^ it is possible that the Gln^239^ → X variants excluded CTAD-Asn^803^ from the proper conformation, which could impede access of O~2~ to the Fe(II) as well as hydroxylation by the putative ferryl intermediate (Scheme [2](#sch2){ref-type="scheme"}).

Conclusion {#sec5}
==========

This work establishes that proper positioning of the primary substrate (CTAD) is required to support coupled turnover by FIH. We conclude that proper positioning of substrate is crucial for the hydroxylation of CTAD as well as for stimulation of O~2~ activation. Mispositioned CTAD impedes O~2~ activation, suggesting that the environment near the Fe(II) cofactor plays a marked role in O~2~ activation.

Control experiments showing the thermal stability of the Gln^239^ → X variant and intrinsic tryptophan fluorescence titrations with CTAD. This material is available free of charge via the Internet at <http://pubs.acs.org>.
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αKG

:   α-ketoglutarate

CAS

:   clavaminate synthase

CD

:   circular dichroism

CREBP

:   cAMP response element-binding protein

CTAD

:   C-terminal transactivation domain

DFT

:   density functional theory

DTT

:   dithiothreitol

FIH

:   factor-inhibiting HIF

HAT

:   hydrogen atom transfer

HEPES

:   4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid

HIF

:   hypoxia inducible factor-1α

MCD

:   magnetic circular dichroism

NOG

:   *N*-oxalyl glycine

P4H

:   prolyl-4-hydroxylase

SKIE

:   solvent kinetic isotope effect

TauD

:   taurine dioxygenase.
